Literature DB >> 16218885

Current options for the treatment of impetigo in children.

Michael J Sladden1, Graham A Johnston.   

Abstract

Impetigo contagiosa is a common, superficial, bacterial infection of the skin characterised by an inflamed and infected epidermis caused by Staphylococcus aureus, Streptococcus pyogenes or both. The less common bullous impetigo is characterised by fragile fluid-filled vesicles and flaccid blisters, and is invariably caused by pathogenic strains of S. aureus. In bullous impetigo, exfoliative toxins are produced, although these are restricted to the area of infection and bacteria can be cultured from the blister contents. In the rare variant, staphylococcal scalded skin syndrome, the exfoliative toxins are spread haematogenously from a localised source causing widespread epidermal damage at distant sites.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16218885     DOI: 10.1517/14656566.6.13.2245

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  3 in total

1.  Staphylococcus aureus decolonization for recurrent skin and soft tissue infections in children.

Authors:  Christine H Smith; Ran D Goldman
Journal:  Can Fam Physician       Date:  2012-12       Impact factor: 3.275

2.  Ozenoxacin, a New Effective and Safe Topical Treatment for Impetigo in Children and Adolescents.

Authors:  Antonio Torrelo; Ramon Grimalt; Xavier Masramon; Núria Albareda López; Ilonka Zsolt
Journal:  Dermatology       Date:  2020-01-20       Impact factor: 5.366

3.  Safety and efficacy profile of ozenoxacin 1% cream in pediatric patients with impetigo.

Authors:  Adelaide A Hebert; Theodore Rosen; Núria Albareda López; Ilonka Zsolt; Xavier Masramon
Journal:  Int J Womens Dermatol       Date:  2019-11-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.